Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise
- Autores
- Bouzat, Cecilia Beatriz
- Año de publicación
- 2025
- Idioma
- inglés
- Tipo de recurso
- documento de conferencia
- Estado
- versión publicada
- Descripción
- Pentameric ligand-gated ion channels (pLGICs) are essential for translating neurotransmitter recognition into electrical signals in both vertebrates and invertebrates, contributing to fundamental processes such as movement, memory, cognition, and synaptic plasticity. These receptors are expressed not only in the nervous system but also in various non-neuronal cells, and are implicated in a wide spectrum of disorders, making them key pharmacological targets for clinically relevant drugs. In vertebrates, the pLGIC family includes cation-selective channels—nicotinic acetylcholine receptors (nAChRs) and serotonin type 3 receptors—as well as anion-selective channels such as glycine and GABAA_A receptors, whereas in invertebrates the repertoire is even more diverse. Remarkably, the free-living nematode Caenorhabditis elegans—a model for both human diseases and anthelmintic drug discovery—possesses one of the largest and most varied pLGIC families, making it an ideal system for investigating their function and therapeutic potential. Using a combination of experimental approaches, including high-resolution patch-clamp recordings primarily focused on nicotinic and serotonin receptors, we characterized their kinetic and functional properties and identified novel modulatory compounds, providing valuable insights into their potential as therapeutic targets. Extending this framework to C. elegans, we bridged molecular and organismal levels to uncover functional features of nematode pLGICs— some conserved and relevant to human diseases, others uniquely nematode-specific and emerging as anthelmintic targets. These findings highlight new molecular targets and lead compounds for the development of novel therapies. Our work offers insights into receptor function under both physiological and pathological conditions, paving the way for innovative therapeutic applications.
Fil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
XLVI Congreso Anual de la Sociedad de Farmacología de Chile
Valdivia
Chile
Sociedad de Farmacología de Chile - Materia
-
LIGAND-GATED ION CHANNEL
NICOTINIC RECEPTOR
PATCH CLAMP
MODULATION - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/289769
Ver los metadatos del registro completo
| id |
CONICETDig_c98865f78caeda6b7b042e5e9e8b2071 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/289769 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promiseBouzat, Cecilia BeatrizLIGAND-GATED ION CHANNELNICOTINIC RECEPTORPATCH CLAMPMODULATIONhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Pentameric ligand-gated ion channels (pLGICs) are essential for translating neurotransmitter recognition into electrical signals in both vertebrates and invertebrates, contributing to fundamental processes such as movement, memory, cognition, and synaptic plasticity. These receptors are expressed not only in the nervous system but also in various non-neuronal cells, and are implicated in a wide spectrum of disorders, making them key pharmacological targets for clinically relevant drugs. In vertebrates, the pLGIC family includes cation-selective channels—nicotinic acetylcholine receptors (nAChRs) and serotonin type 3 receptors—as well as anion-selective channels such as glycine and GABAA_A receptors, whereas in invertebrates the repertoire is even more diverse. Remarkably, the free-living nematode Caenorhabditis elegans—a model for both human diseases and anthelmintic drug discovery—possesses one of the largest and most varied pLGIC families, making it an ideal system for investigating their function and therapeutic potential. Using a combination of experimental approaches, including high-resolution patch-clamp recordings primarily focused on nicotinic and serotonin receptors, we characterized their kinetic and functional properties and identified novel modulatory compounds, providing valuable insights into their potential as therapeutic targets. Extending this framework to C. elegans, we bridged molecular and organismal levels to uncover functional features of nematode pLGICs— some conserved and relevant to human diseases, others uniquely nematode-specific and emerging as anthelmintic targets. These findings highlight new molecular targets and lead compounds for the development of novel therapies. Our work offers insights into receptor function under both physiological and pathological conditions, paving the way for innovative therapeutic applications.Fil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; ArgentinaXLVI Congreso Anual de la Sociedad de Farmacología de ChileValdiviaChileSociedad de Farmacología de ChileSociedad de Farmacología de Chile2025info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectCongresoJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/289769Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise; XLVI Congreso Anual de la Sociedad de Farmacología de Chile; Valdivia; Chile; 2025; 7-7CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://temasdesalud.cl/evento/xlvi-congreso-anual-de-la-sociedad-de-farmacologia-de-chile-2-al-5-de-diciembre-de-2025/info:eu-repo/semantics/altIdentifier/url/https://www.sofarchi.cl/wp-content/uploads/Revista-Farmacologia-Vol1_2025.pdfInternacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2026-08-25T15:49:10Zoai:ri.conicet.gov.ar:11336/289769instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982026-08-25 15:49:10.566CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise |
| title |
Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise |
| spellingShingle |
Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise Bouzat, Cecilia Beatriz LIGAND-GATED ION CHANNEL NICOTINIC RECEPTOR PATCH CLAMP MODULATION |
| title_short |
Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise |
| title_full |
Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise |
| title_fullStr |
Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise |
| title_full_unstemmed |
Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise |
| title_sort |
Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise |
| dc.creator.none.fl_str_mv |
Bouzat, Cecilia Beatriz |
| author |
Bouzat, Cecilia Beatriz |
| author_facet |
Bouzat, Cecilia Beatriz |
| author_role |
author |
| dc.subject.none.fl_str_mv |
LIGAND-GATED ION CHANNEL NICOTINIC RECEPTOR PATCH CLAMP MODULATION |
| topic |
LIGAND-GATED ION CHANNEL NICOTINIC RECEPTOR PATCH CLAMP MODULATION |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
| dc.description.none.fl_txt_mv |
Pentameric ligand-gated ion channels (pLGICs) are essential for translating neurotransmitter recognition into electrical signals in both vertebrates and invertebrates, contributing to fundamental processes such as movement, memory, cognition, and synaptic plasticity. These receptors are expressed not only in the nervous system but also in various non-neuronal cells, and are implicated in a wide spectrum of disorders, making them key pharmacological targets for clinically relevant drugs. In vertebrates, the pLGIC family includes cation-selective channels—nicotinic acetylcholine receptors (nAChRs) and serotonin type 3 receptors—as well as anion-selective channels such as glycine and GABAA_A receptors, whereas in invertebrates the repertoire is even more diverse. Remarkably, the free-living nematode Caenorhabditis elegans—a model for both human diseases and anthelmintic drug discovery—possesses one of the largest and most varied pLGIC families, making it an ideal system for investigating their function and therapeutic potential. Using a combination of experimental approaches, including high-resolution patch-clamp recordings primarily focused on nicotinic and serotonin receptors, we characterized their kinetic and functional properties and identified novel modulatory compounds, providing valuable insights into their potential as therapeutic targets. Extending this framework to C. elegans, we bridged molecular and organismal levels to uncover functional features of nematode pLGICs— some conserved and relevant to human diseases, others uniquely nematode-specific and emerging as anthelmintic targets. These findings highlight new molecular targets and lead compounds for the development of novel therapies. Our work offers insights into receptor function under both physiological and pathological conditions, paving the way for innovative therapeutic applications. Fil: Bouzat, Cecilia Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina XLVI Congreso Anual de la Sociedad de Farmacología de Chile Valdivia Chile Sociedad de Farmacología de Chile |
| description |
Pentameric ligand-gated ion channels (pLGICs) are essential for translating neurotransmitter recognition into electrical signals in both vertebrates and invertebrates, contributing to fundamental processes such as movement, memory, cognition, and synaptic plasticity. These receptors are expressed not only in the nervous system but also in various non-neuronal cells, and are implicated in a wide spectrum of disorders, making them key pharmacological targets for clinically relevant drugs. In vertebrates, the pLGIC family includes cation-selective channels—nicotinic acetylcholine receptors (nAChRs) and serotonin type 3 receptors—as well as anion-selective channels such as glycine and GABAA_A receptors, whereas in invertebrates the repertoire is even more diverse. Remarkably, the free-living nematode Caenorhabditis elegans—a model for both human diseases and anthelmintic drug discovery—possesses one of the largest and most varied pLGIC families, making it an ideal system for investigating their function and therapeutic potential. Using a combination of experimental approaches, including high-resolution patch-clamp recordings primarily focused on nicotinic and serotonin receptors, we characterized their kinetic and functional properties and identified novel modulatory compounds, providing valuable insights into their potential as therapeutic targets. Extending this framework to C. elegans, we bridged molecular and organismal levels to uncover functional features of nematode pLGICs— some conserved and relevant to human diseases, others uniquely nematode-specific and emerging as anthelmintic targets. These findings highlight new molecular targets and lead compounds for the development of novel therapies. Our work offers insights into receptor function under both physiological and pathological conditions, paving the way for innovative therapeutic applications. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/conferenceObject Congreso Journal http://purl.org/coar/resource_type/c_5794 info:ar-repo/semantics/documentoDeConferencia |
| status_str |
publishedVersion |
| format |
conferenceObject |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/289769 Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise; XLVI Congreso Anual de la Sociedad de Farmacología de Chile; Valdivia; Chile; 2025; 7-7 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/289769 |
| identifier_str_mv |
Pentameric ligand-gated ion channels: Bridging molecular Insights and clinical promise; XLVI Congreso Anual de la Sociedad de Farmacología de Chile; Valdivia; Chile; 2025; 7-7 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://temasdesalud.cl/evento/xlvi-congreso-anual-de-la-sociedad-de-farmacologia-de-chile-2-al-5-de-diciembre-de-2025/ info:eu-repo/semantics/altIdentifier/url/https://www.sofarchi.cl/wp-content/uploads/Revista-Farmacologia-Vol1_2025.pdf |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf |
| dc.coverage.none.fl_str_mv |
Internacional |
| dc.publisher.none.fl_str_mv |
Sociedad de Farmacología de Chile |
| publisher.none.fl_str_mv |
Sociedad de Farmacología de Chile |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1874775839966494720 |
| score |
13.24418 |